Immunotherapy Shows Promise in Tough-to-Treat Mesothelioma

(MedPage Today) -- Outcomes improved with nivolumab alone or with impilimumab in pretreated patients
Source: MedPage Today Meeting Coverage - Category: General Medicine Source Type: news